Email nick.bansback@ubc.ca

A fundamental objective of health systems is to determine the best use of the limited funds to promote health and provide equitable, transparent and sustainable health care. Dr Bansback’s research focuses on measuring and maximizing the value of health care to inform how funding should be spent. His work not only considers the value that patients derive from their own care and treatment options, but the value the whole population derives from the investment in health care.

• NUS Saw Swee Hock School of Public Health (Honorary visiting)
• Associate Professor, School of Population and Public Health, University of British Columbia, Canada (Primary)

• Economic evaluation
• Measuring preferences and values
• Patient Reported Outcomes
• Predicting preference based uptake and behaviour

• Health Economics
• Decision Analysis
• Health Technology Assessment

• PhD in Health Economics and Decision Sciences (2010), University of Sheffield, UK
• MSc in Health Economics (2004), University of Sheffield, UK
• BSc in Mathematics (2001), University of Sheffield, UK

• University of British Columbia Killam Research Award (2020)
• Canadian Arthritis Alliance Knowledge Translation Research (2017)
• Canadian Agency for Drugs and Technology in Health Maurice McGregor Rising Star in Health Technology Assessment (2016)
• Canadian Institutes of Health Research New Investigator Award (2014)

• Post-doctoral Fellow, University of British Columbia (2010-2012)
• Health Economist, Centre for Health Evaluation and Outcomes Sciences (2004-2010)
• Research Fellow, School of Health And Related Research, University of Sheffield (2001-2004)

• Bansback N, Trenaman L, Mulhern BJ, Norman R, Metcalfe R, Sawatzky R, Brazier JE, Rowen D, Whitehurst DGT. Estimation of a Canadian preference-based scoring algorithm for the Veterans RAND 12-Item Health Survey: a population survey using a discrete-choice experiment. CMAJ Open. 2022;10(3):E589-E598.
• Bansback N, Trenaman L, MacDonald KV, Hawker G, Johnson JA, Smith C, Stacey D, Marshall DA. An online individualised patient decision aid improves the quality of decisions in patients considering total knee arthroplasty in routine care: A randomized controlled trial. Osteoarthritis and Cartilage Open. 2022;4(3):100286
• Bansback N, Chiu JA, Metcalfe R, Lapointe E, Schabas A, Lenzen M, Traboulsee A, Lynd LD, Carruthers R. Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 2021;7(3):20552173211029966.
• Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial. Addiction. 2018;113(7):1264-1273
• Bansback N, Phibbs CS, Sun H, O’Dell JR, Brophy M, Keystone EC, Leatherman S, Mikuls TR, Anis AH. Triple therapy versus biologic therapy for active rheumatoid arthritis: A cost-effectiveness analysis. Annals of Internal Medicine. 2017;167(1):8-16
• Bansback N, Shojania K, Lacaille D. An Overdue Choice: Improving Patient-Centred Care in Rheumatoid Arthritis. CMAJ. 2016;188(14):999.
• Bansback N, Harrison M, Sadatsafavi M, Stiggelbout A, Whitehurst D. Attitude to health risk in the Canadian Population: evidence from a nationwide cross-sectional survey. CMAJ Open. 2016;4(2):E284-91.
• Bansback N, Harrison M, Marra C. Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments? Medical Decision Making. 2016;36(4):490-502.
• Bansback N, Keystone E, O’Dell J, Phibbs CS, Hannagan K, Brophy M, Anis A. Making smart investment decisions in clinical research. Trials. 2015;16(1):590.
• Bansback N, Hole AR, Mulhern B, Tsuchiya A. Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues. Social Science & Medicine. 2014;114(100):38-48.
• Bansback N, Brazier J, Tsuchiya A, Anis A. Using a discrete choice experiment to estimate health state utility values. Journal of Health Economics. 2012;31(1):306-18.
• Bansback N, Tsuchiya A, Brazier J, Anis A. Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies. PLoS ONE. 2012;7(2):e31115.